Department of Cancer Prevention
Department head: Ragnhild A. Lothe, Professor
Department administrative consultants: Mona Hagen and Linda Uv Mjøen
Lab manager: Guro Elisabeth Lind
- Molecular Genetics Group, headed by Professor Ragnhild A. Lothe
- Genome Biology Group, headed by Rolf I. Skotheim
- Epigenetics Group, headed by Guro Elisabeth Lind
|Molecular Genetics||Genome Biology||Epigenetics|
|Ragnhild A. Lothe||Rolf I. Skotheim||Guro E. Lind|
The Department for Cancer Prevention is a member of Centre for Cancer Biomedicine, a Norwegian Centre of Excellence affiliated with the University of Oslo.
Lothe and Skotheim, together with researchers and clinicians from all Norwegian health regions, are partners in the Norwegian Cancer Genomics Consortium, where deep sequencing of cancer patients is performed to evaluate genome-based diagnostics for improved therapy decisions.
On Thursday, November 28th, at 13:15, Torfinn Nome will defend his thesis "Novel RNA variants in colorectal cancer identified by deep sequencing" for the PhD degree.
Earlier the same day, at 10:15, his trial lecture will be given over the topic "Will deep sequencing and bioinformatics improve the success rate of translating cancer biomarkers to the clinic?".
Nome has performed his PhD in the Genome Biology Group at the Department of Cancer Prevention.
Department of Cancer Prevention, Institute for Cancer Research
Oslo University Hospital HE - Norwegian Radium Hospital
Mail address: P. O. Box 4953 Nydalen, NO-0424 Oslo, Norway
Street address: Norwegian Radium Hospital, Montebello
Phone: +47 2278 1728, Switchboard: +47 2293 4000, Fax: +47 2278 1745
Nov 26, 2013
Sep 9, 2013
Apr 28, 2013
Apr 23, 2013
Dept of Cancer Prevention
BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell Cultures
Stem Cell Reports, 1 (5), 379-386
Identification of Highly Methylated Genes across Various Types of B-Cell Non-Hodgkin Lymphoma
PLoS One, 8 (11), e79602